Adolescents with IBD: The importance of structured transition care

Journal of Crohn's and Colitis

Volumn 5, Issue 6, 2011, Pages 509-519

  Goodhand, J ^a   Hedin, C R ^a   Croft, N M ^a   Lindsay, J O ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adolescents; Crohn's disease; Inflammatory bowel disease; Medical care; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BIOLOGICAL PRODUCT; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ABDOMINAL RADIOGRAPHY; ADOLESCENCE; ADOLESCENT; AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; BIOLOGICAL THERAPY; CAREGIVER; CHILDHOOD; CHRONIC DISEASE; COGNITIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CROHN DISEASE; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GEOGRAPHY; GROWTH DISORDER; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH SERVICE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL SERVICE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KNOWLEDGE; LIFESTYLE; LIFESTYLE MODIFICATION; MEDICAL CARE; MEDICAL SPECIALIST; MONOTHERAPY; NEOPLASM; OPPORTUNISTIC INFECTION; OUTPATIENT CARE; PATIENT COMPLIANCE; PEDIATRICS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; PUBERTY; PUBLICATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; T CELL LYMPHOMA; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNITED KINGDOM; UPPER GASTROINTESTINAL ENDOSCOPY;

ADOLESCENT; AGE FACTORS; CONTINUITY OF PATIENT CARE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE TEAM; TRANSITION TO ADULT CARE;

EID: 82255175223     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.03.015     Document Type: Review

References (93)

1. Sawczenko A., Sandhu B.K. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003, 88:995-1000.
2. Sawczenko A., Sandhu B.K., Logan R.F., Jenkins H., Taylor C.J., Mian S., Lynn R. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001, 357:1093-1094.
3. Lehtinen P., Ashorn M., Iltanen S., Jauhola R., Jauhonen P., Kolho K.L., Auvinen A. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study. Inflamm Bowel Dis 2010, [epub ahead of print] PMID: 21080459.
4. Benchimol E.I., Guttmann A., To T., Rabeneck L., Griffiths A.M. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007). Inflamm Bowel Dis 2010, [epub ahead of print] PMID: 21182021.
5. Van Limbergen J., Russell R.K., Drummond H.E., Aldhous M.C., Round N.K., Nimmo E.R., Smith L., Gillett P.M., McGrogan P., Weaver L.T., Bisset W.M., Mahdi G., Arnott I.D., Satsangi J., Wilson D.C. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008, 135:1114-1122.
6. Vernier-Massouille G., Balde M., Salleron J., Turck D., Dupas J.L., Mouterde O., Merle V., Salomez J.L., Branche J., Marti R., Lerebours E., Cortot A., Gower-Rousseau C., Colombel J.F. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008, 135:1106-1113.
7. Goodhand J., Dawson R., Hefferon M., Tshuma N., Swanson G., Wahed M., Croft N.M., Lindsay J.O. Inflammatory bowel disease in young people: the case for transitional clinics. Inflamm Bowel Dis 2010, 16:947-952.
8. Nieuwenhuis E.E., Escher J.C. Early onset IBD: what's the difference?. Dig Liver Dis 2008, 40:12-15.
9. Gupta N., Bostrom A.G., Kirschner B.S., Cohen S.A., Abramson O., Ferry G.D., Gold B.D., Winter H.S., Baldassano R.N., Smith T., Heyman M.B. Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol 2008, 103:2092-2098.
10. Rosen D.S. Pubertal growth and sexual maturation for adolescents with chronic illness or disability. Pediatrician 1991, 18:105-120.
11. DOH National service framework for children, young people and maternity services: The mental health and psychological wellbeing of children and young people Available at:. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4089114.
12. Van Assche G., Dignass A., Reinisch W., Janneke van der Woude C., Sturm A., De Vos M., Guslandi M., Oldenburg B., Dotan I., Marteau P., Ardizzone A., Baumgart D.C., D'Haens G., Gionchetti P., Portela F., Vucelic B., Soderholm J., Escher J., Koletzko S., Kolho K.L., Lukas M., Mottet C., Tilg H., Vermeire S., Carbonnel F., Cole A., Novacek G., Reinshagen M., Tsianos E., Herrlinger K., Bouhnik Y., Kiesslich R., Stange E.F., Travis S., Lindsay J. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010, 4:63-101.
13. Baldassano R., Ferry G., Griffiths A., Mack D., Markowitz J., Winter H. Transition of the patient with inflammatory bowel disease from paediatric to adult care: recommendations of the North American Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2002, 34:245-248.
14. Leung Y., Heyman M.B., Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: Guidelines for the adult and paediatric gastroenterologist. Inflamm Bowel Dis 2010, Dec 16. [Epub ahead of print]. PMID: 21165960.
15. Christie D., Viner R. Adolescent development. BMJ 2005, 330:301-304.
16. Pinzon J.L., Jacobson K., Reiss J. Say goodbye and say hello: the transition from paediatric to adult gastroenterology. Can J Gastroenterol 2004, 18:735-742.
17. Hait E.J., Arnold J.H., Sands B.E., Fishman L. Transition to adult care. Pediatric and inflammatory bowel disease: Perspective and Consequences Volume 14 2009, 191-198. Karger, Basel. J.A. Walker-Smith, E. Lebenthal, D. Branski (Eds.).
18. Giarelli E., Bernhardt B.A., Mack R., Pyeritz R.E. Adolescents' transition to self-management of a chronic genetic disorder. Qual Health Res 2008, 18:441-457.
19. Blum R.W., Garell D., Hodgman C.H., Jorissen T.W., Okinow N.A., Orr D.P., Slap G.B. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health 1993, 14:570-576.
20. Rubin G.P., Hungin A.P., Kelly P.J., Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000, 14:1553-1559.
21. Armitage E., Drummond H.E., Wilson D.C., Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001, 13:1439-1447.
22. Lakatos P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J Gastroenterol 2006, 12:6102-6108.
23. Tsironi E., Feakins R.M., Probert C.S., Rampton D.S. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004, 99:1749-1755.
24. Abdullah B.A., Gupta S.K., Croffie J.M., Pfefferkorn M.D., Molleston J.P., Corkins M.R., Fitzgerald J.F. The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study. J Pediatr Gastroenterol Nutr 2002, 35:636-640.
25. Castellaneta S.P., Afzal N.A., Greenberg M., Deere H., Davies S., Murch S.H., Walker-Smith J.A., Thomson M., Srivistrava A. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004, 39:257-261.
26. Mashako M.N., Cezard J.P., Navarro J., Mougenot J.F., Sonsino E., Gargouri A., Maherzi A. Crohn's disease lesions in the upper gastrointestinal tract: correlation between clinical, radiological, endoscopic, and histological features in adolescents and children. J Pediatr Gastroenterol Nutr 1989, 8:442-446.
27. Sharif F., McDermott M., Dillon M., Drumm B., Rowland M., Imrie C., Kelleher S., Harty S., Bourke B. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol 2002, 97:1415-1420.
28. Shamir R. Nutritional aspects in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009, 48(Suppl 2):S86-8.
29. Heuschkel R., Salvestrini C., Beattie R.M., Hildebrand H., Walters T., Griffiths A. Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:839-849.
30. Sanderson I.R., Croft N.M. The anti-inflammatory effects of enteral nutrition. JPEN J Parenter Enteral Nutr 2005, 29:S134-8.
31. Heuschkel R.B., Menache C.C., Megerian J.T., Baird A.E. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000, 31:8-15.
32. Muller K.R., Prosser R., Bampton P., Mountifield R., Andrews J.M. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis 2010, 16:657-663.
33. Colombel J.F., Sandborn W.J., Reinisch W., Mantzaris G.J., Kornbluth A., Rachmilewitz D., Lichtiger S., D'Haens G., Diamond R.H., Broussard D.L., Tang K.L., van der Woude C.J., Rutgeerts P. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010, 362:1383-1395.
34. Panaccione R., Ghosh S., Middleton S., Velazquez J.R.M., Khalif I., Flint L., van Hoogstraten H.J., Zheng H., Danese S., Rutgeerts P. Infliximab, azathioprine or infliximab + azathioprine for treatment of moderate to severe ulcerative colitis: The UC SUCCESS trial. J Crohns Colitis 2011, 5:S8-9.
35. Toruner M., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Orenstein R., Sandborn W.J., Colombel J.F., Egan L.J. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008, 134:929-936.
36. Rosh J.R., Gross T., Mamula P., Griffiths A., Hyams J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?. Inflamm Bowel Dis 2007 Aug, 13(8):1024-1030.
37. van der Woude C.J., Kolacek S., Dotan I., Oresland T., Vermeire S., Munkholm P., Mahadevan U., Mackillop L., Dignass A. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010, 4:493-510.
38. Goodhand J., Rampton D. Psychological stress and coping in IBD. Gut 2008, 57:1345-1347.
39. Goodhand J.R., Wahed M., Rampton D.S. Management of stress in inflammatory bowel disease: a therapeutic option?. Expert Rev Gastroenterol Hepatol 2009, 3:661-679.
40. Persoons P., Vermeire S., Demyttenaere K., Fischler B., Vandenberghe J., Van Oudenhove L., Pierik M., Hlavaty T., Van Assche G., Noman M., Rutgeerts P. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther 2005, 22:101-110.
41. Porcelli P., Leoci C., Guerra V. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996, 31:792-796.
42. Szigethy E., Craig A.E., Iobst E.A., Grand R.J., Keljo D., Demaso D., Noll R. Profile of depression in adolescents with inflammatory bowel disease: implications for treatment. Inflamm Bowel Dis 2009, 15:69-74.
43. Szigethy E., Levy-Warren A., Whitton S., Bousvaros A., Gauvreau K., Leichtner A.M., Beardslee W.R. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr 2004, 39:395-403.
44. van der Zaag-Loonen H.J., Grootenhuis M.A., Last B.F., Derkx H.H. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Qual Life Res 2004, 13:1011-1019.
45. Bitton A., Dobkin P.L., Edwardes M.D., Sewitch M.J., Meddings J.B., Rawal S., Cohen A., Vermeire S., Dufresne L., Franchimont D., Wild G.E. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut 2008, 57:1386-1392.
46. Arnott I.D., Leiper K., Lowe D., Driscoll R., Senapati A., Rhodes J., Down C., Moloney C. UK IBD Audit (2nd round): Executive summary of the national results for the organisation & process of adult IBD care in the UK Available at:. http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/IBD/Documents/Executive-Summary-of-the-UK-IBD-Audit-2nd-round-(2008)-Report.pdf.
47. Hait E.J., Barendse R.M., Arnold J.H., Valim C., Sands B.E., Korzenik J.R., Fishman L.N. Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr 2009, 48:61-65.
48. Sebastian S., McCartney S., Croft N.M., Russel R., Ahmed T., Jenkins H., Lindsay J.O. Barriers to transition care for adolescents with inflammatory bowel disease: results of of a postal survey of adult and paediatric gastroenterologists. J Crohns Colitis 2011.
49. Desmond A.N., O'Regan K., Curran C., McWilliams S., Fitzgerald T., Maher M.M., Shanahan F. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut 2008, 57:1524-1529.
50. Cardis E., Vrijheid M., Blettner M., Gilbert E., Hakama M., Hill C., Howe G., Kaldor J., Muirhead C.R., Schubauer-Berigan M., Yoshimura T., Bermann F., Cowper G., Fix J., Hacker C., Heinmiller B., Marshall M., Thierry-Chef I., Utterback D., Ahn Y.O., Amoros E., Ashmore P., Auvinen A., Bae J.M., Solano J.B., Biau A., Combalot E., Deboodt P., Diez Sacristan A., Eklof M., Engels H., Engholm G., Gulis G., Habib R., Holan K., Hyvonen H., Kerekes A., Kurtinaitis J., Malker H., Martuzzi M., Mastauskas A., Monnet A., Moser M., Pearce M.S., Richardson D.B., Rodriguez-Artalejo F., Rogel A., Tardy H., Telle-Lamberton M., Turai I., Usel M., Veress K. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ 2005, 331:77.
51. Brenner D.J., Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007, 357:2277-2284.
52. Szigethy E., Kenney E., Carpenter J., Hardy D.M., Fairclough D., Bousvaros A., Keljo D., Weisz J., Beardslee W.R., Noll R., DeMaso D.R. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry 2007, 46:1290-1298.
53. Wahed M., Corser M., Goodhand J.R., Rampton D.S. Does psychological counseling alter the natural history of inflammatory bowel disease?. Inflamm Bowel Dis 2010, 16:664-669.
54. Miehsler W., Weichselberger M., Offerlbauer-Ernst A., Dejaco C., Reinisch W., Vogelsang H., Machold K., Stamm T., Gangl A., Moser G. Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis 2008, 14:1273-1280.
55. Brumfield K., Lansbury G. Experiences of adolescents with cystic fibrosis during their transition from paediatric to adult health care: a qualitative study of young Australian adults. Disabil Rehabil 2004, 26:223-234.
56. Busse F.P., Hiermann P., Galler A., Stumvoll M., Wiessner T., Kiess W., Kapellen T.M. Evaluation of patients' opinion and metabolic control after transfer of young adults with type 1 diabetes from a pediatric diabetes clinic to adult care. Horm Res 2007, 67:132-138.
57. Moons P., Pinxten S., Dedroog D., Van Deyk K., Gewillig M., Hilderson D., Budts W. Expectations and experiences of adolescents with congenital heart disease on being transferred from pediatric cardiology to an adult congenital heart disease program. J Adolesc Health 2009, 44:316-322.
58. Wray J., Maynard L. Specialist cardiac services: what do young people want?. Cardiol Young 2008, 18:569-574.
59. Hauser E.S., Dorn L. Transitioning adolescents with sickle cell disease to adult-centred care. Pediatr Nurs 1999, 25:479-488.
60. McCurdy C., DiCenso A., Boblin S., Ludwin D., Bryant-Lukosius D., Bosompra K. There to here: young adult patients' perceptions of the process of transition from paediatric to adult transplant care. Prog Transplant 2006, 16:309-316.
61. Stabile L., Rosser L., Porterfield K.M., McCauley S., Levenson C., Haglund J., Christman K. Transfer versus transition: success in paediatric transplantation brings the welcome challenge of transition. Prog Transplant 2005, 15:363-370.
62. de Beaufort C., Jarosz-Chobot P., Frank M., de Bart J., Deja G. Transition from paediatric to adult diabetes care: smooth or slippery?. Pediatr Diabetes 2010, 11:24-27.
63. Tuchman L.K., Schwartz L.A., Sawicki G.S., Britto M.T. Cystic fibrosis and transition to adult medical care. Pediatrics 2010, 125:566-573.
64. Tuchman L.K., Slap G.B., Britto M.T. Transition to adult care: experiences and expectations of adolescents with a chronic illness. Child Care Health Dev 2008, 34:557-563.
65. Benchimol E.I., Walters T.D., Kaufman M., Frost K., Fiedler K., Chinea Z., Zachos M. Assessment of knowledge in adolescents with inflammatory bowel disease using a novel transition tool. Inflamm Bowel Dis 2011, 17(5):1131-1137. 10.1002/ibd.21464.
66. Good 2 Go Transition Program Available at:. http://www.sickkids.ca/good2go/.
67. MyHealth Passport Available at:. http://www.sickkids.ca/Good2Go/What-we-do/MyHealth-Passport/index.html.
68. Knauth Meadows A., Bosco V., Tong E., Fernandes S., Saidi A. Transition and transfer from paediatric to adult care of young adults with complex congenital heart disease. Curr Cardiol Rep 2009, 11:291-297.
69. Wacker A., Kaemmerer H., Hollweck R., Hauser M., Deutsch M.A., Brodherr-Heberlein S., Eicken A., Hess J. Outcome of operated and un-operated adults with congenital cardiac disease lost to follow-up for more than five years. Am J Cardiol 2005, 95:776-779.
70. Yeung E., Kay J., Roosevelt G.E., Brandon M., Yetman A.T. Lapse of care as a predictor for morbidity in adults with congenital heart disease. Int J Cardiol 2008, 125:62-65.
71. Reid G.J., Irvine M.J., McCrindle B.W., Sananes R., Ritvo P.G., Siu S.C., Webb G.D. Prevalence and correlates of successful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects. Pediatrics 2004, 113:e197-205.
72. Moons P., Hilderson D., Van Deyk K. Implementation of transition programs can prevent another lost generation of patients with congenital heart disease. Eur J Cardiovasc Nurs 2008, 7:259-263.
73. Gurvitz M.Z., Inkelas M., Lee M., Stout K., Escarce J., Chang R.K. Changes in hospitalization patterns among patients with congenital heart disease during the transition from adolescence to adulthood. J Am Coll Cardiol 2007, 49:875-882.
74. Nakhla M., Daneman D., To T., Paradis G., Guttmann A. Transition to adult care for youths with diabetes mellitus: findings from a Universal Health Care System. Pediatrics 2009, 124:1134-1141.
75. Sabate E. Adherence to long-term therapies: Evidence for action 2003, World Health Organisation, Geneva, Switzerland.
76. Dobbels F., Van Damme-Lombaert R., Vanhaecke J., De Geest S. Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005, 9:381-390.
77. Danne T., Mortensen H.B., Hougaard P., Lynggaard H., Aanstoot H.J., Chiarelli F., Daneman D., Dorchy H., Garandeau P., Greene S.A., Hoey H., Holl R.W., Kaprio E.A., Kocova M., Martul P., Matsuura N., Robertson K.J., Schoenle E.J., Sovik O., Swift P.G., Tsou R.M., Vanelli M., Aman J. Persistent differences among centres over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 2001, 24:1342-1347.
78. Cadario F., Prodam F., Bellone S., Trada M., Binotti M., Trada M., Allochis G., Baldelli R., Esposito S., Bona G., Aimaretti G. Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach. Clin Endocrinol (Oxf) 2009, 71:346-350.
79. Greenley R.N., Stephens M., Doughty A., Raboin T., Kugathasan S. Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2010, 16:36-41.
80. Ingerski L.M., Baldassano R.N., Denson L.A., Hommel K.A. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol 2010, 35:683-691.
81. Reed-Knight B., Lewis J.D., Blount R.L. Association of Disease, Adolescent, and Family Factors with Medication Adherence in Pediatric Inflammatory Bowel Disease. J Pediatr Psychol 2011, 36(3):308-317.
82. Goodhand J.R., Tshuma N., Rao A., Kotta S., Wahed M., Croft N.M., Sanderson I.R., Epstein J., Rampton D.S. Do children with IBD really respond better than adults to thiopurines?. J Pediatr Gastroenterol Nutr 2011, [epub ahead of print].
83. Annunziato R.A., Emre S., Shneider B.L., Dugan C.A., Aytaman Y., McKay M.M., Shemesh E. Transitioning health care responsibility from caregivers to patient: a pilot study aiming to facilitate medication adherence during this process. Pediatr Transplant 2008, 12:309-315.
84. Holmes-Walker D.J., Llewellyn A.C., Farrell K. A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15-25 years. Diabet Med 2007, 24:764-769.
85. McDonagh J.E., Southwood T.R., Shaw K.L. The impact of a coordinated transitional care programme on adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) 2007, 46:161-168.
86. Paone M.C., Wigle M., Saewyc E. The ON TRAC model for transitional care of adolescents. Prog Transplant 2006, 16:291-302.
87. Escher J.C. Transition from paediatric to adult health care in inflammatory bowel disease. Dig Dis 2009, 27:382-386.
88. Dabadie A., Troadec F., Heresbach D., Siproudhis L., Pagenault M., Bretagne J.F. Transition of patients with inflammatory bowel disease from pediatric to adult care. Gastroenterol Clin Biol 2008, 32:451-459.
89. Van Pieterson M., van der Toorn P., van der Woude C.J., Escher J.C. Transition of care in IBD:expectations and outcomes in adolescents and young adults. J Pediatr Gastroenterol Nutr 2007, 44:e95.
90. Reiss J.G., Gibson R.W., Walker L.R. Health care transition: youth, family, and provider perspectives. Pediatrics 2005, 115:112-120.
91. van Pelt P.A., Kruize A.A., Goren S.S., van der Net J., Uiterwaal C.S., Kuis W., Bijlsma J.W., Wulffraat N.M. Transition of rheumatologic care, from teenager to adult: which health assessment questionnaire can be best used?. Clin Exp Rheumatol 2010, 28:281-286.
92. Zijlstra M., Breij L., van der Woude C.J., van Pieterson M., Escher J. Assessment of self-efficacy during transition in adolescents with IBD. J Crohns Colitis 2009, 3:S87.
93. Irving P.M., Rampton D.S., Shanahan F. Preface. Clinical dilemmas in inflammatory bowel disease 2006, XIII. Blackwell Publishing, Oxford. P.M. Irving, D.S. Rampton, F. Shanahan (Eds.).